FR2015729A1 - - Google Patents

Info

Publication number
FR2015729A1
FR2015729A1 FR6928043A FR6928043A FR2015729A1 FR 2015729 A1 FR2015729 A1 FR 2015729A1 FR 6928043 A FR6928043 A FR 6928043A FR 6928043 A FR6928043 A FR 6928043A FR 2015729 A1 FR2015729 A1 FR 2015729A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR6928043A
Other languages
French (fr)
Other versions
FR2015729B1 (enExample
Inventor
Jr J A Miller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of FR2015729A1 publication Critical patent/FR2015729A1/fr
Application granted granted Critical
Publication of FR2015729B1 publication Critical patent/FR2015729B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR6928043A 1968-08-15 1969-08-14 Expired FR2015729B1 (enExample)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75278768A 1968-08-15 1968-08-15
US75278868A 1968-08-15 1968-08-15

Publications (2)

Publication Number Publication Date
FR2015729A1 true FR2015729A1 (enExample) 1970-04-30
FR2015729B1 FR2015729B1 (enExample) 1974-02-01

Family

ID=27115647

Family Applications (1)

Application Number Title Priority Date Filing Date
FR6928043A Expired FR2015729B1 (enExample) 1968-08-15 1969-08-14

Country Status (12)

Country Link
BE (1) BE737415A (enExample)
CA (1) CA974451A (enExample)
CY (1) CY782A (enExample)
DE (1) DE1941583C3 (enExample)
FR (1) FR2015729B1 (enExample)
GB (1) GB1250582A (enExample)
IE (1) IE33502B1 (enExample)
IL (1) IL32781A (enExample)
LU (1) LU59283A1 (enExample)
MY (1) MY7500035A (enExample)
NL (1) NL161669C (enExample)
SE (1) SE374269B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU528532B2 (en) * 1978-12-18 1983-05-05 Mcniel Laboratories Acetaminophen analgesic potentiation
EP0068838B1 (en) * 1981-06-26 1986-09-17 The Upjohn Company Analgesic process and composition

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB916242A (en) * 1959-01-07 1963-01-23 Boots Pure Drug Co Ltd Aryloxy aliphatic derivatives and therapeutic compositions containing them

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB916242A (en) * 1959-01-07 1963-01-23 Boots Pure Drug Co Ltd Aryloxy aliphatic derivatives and therapeutic compositions containing them

Also Published As

Publication number Publication date
CA974451A (en) 1975-09-16
SE374269B (enExample) 1975-03-03
NL161669C (nl) 1980-03-17
DE1941583C3 (de) 1980-06-04
DE1941583A1 (de) 1970-07-09
LU59283A1 (enExample) 1970-02-13
IL32781A0 (en) 1969-12-31
MY7500035A (en) 1975-12-31
DE1941583B2 (de) 1979-08-23
NL161669B (nl) 1979-10-15
NL6912502A (enExample) 1970-02-17
BE737415A (enExample) 1970-02-13
CY782A (en) 1975-03-01
FR2015729B1 (enExample) 1974-02-01
GB1250582A (enExample) 1971-10-20
IE33502B1 (en) 1974-07-24
IL32781A (en) 1974-01-14
IE33502L (en) 1970-02-15

Similar Documents

Publication Publication Date Title
AU5506869A (enExample)
AU2374870A (enExample)
AU5184069A (enExample)
AU6168869A (enExample)
AU6171569A (enExample)
AU429879B2 (enExample)
FR2015729B1 (enExample)
AU2581067A (enExample)
AU421558B1 (enExample)
AU3224368A (enExample)
AU4744468A (enExample)
AR203075Q (enExample)
BE709320A (enExample)
AU2496167A (enExample)
BE709095A (enExample)
AU5758767A (enExample)
BE726644A (enExample)
AU4464266A (enExample)
BE718056A (enExample)
AU4503667A (enExample)
AU2889368A (enExample)
BE709435A (enExample)
BE727831A (enExample)
BE709496A (enExample)
BE728604A (enExample)

Legal Events

Date Code Title Description
ST Notification of lapse